Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 11, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 506,000 ordinary shares
- Highest Price Paid: 396.60 pence per share
- Lowest Price Paid: 393.30 pence per share
- Volume Weighted Average Price: 395.0303 pence per share
- Post-Transaction Share Capital: 9,120,364,772 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the 506,000 purchased shares. No other material changes to financial performance or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction. The announcement explicitly states it does not constitute an offer or solicitation of an offer for securities.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the updated total share capital of 9,120,364,772 shares against the company's latest investor relations updates.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution data.
- Check if the repurchase price range (393.30p - 396.60p) aligns with the company's stated valuation targets for the buyback programme.